-
1
-
-
84958888667
-
Committee for Medicinal Products for Human Use (CHMP). Reflection paper on Immune Tolerance Induction in haemophilia A patients with inhibitors. EMA/CHMP/BPWP/153137/2011.
-
Accessed September 4
-
European Medicines Agency (EMA). Committee for Medicinal Products for Human Use (CHMP). Reflection paper on Immune Tolerance Induction in haemophilia A patients with inhibitors. EMA/CHMP/BPWP/153137/2011. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/03/WC500140787.pdf.2011. Accessed September 4, 2015.
-
(2015)
-
-
-
2
-
-
34248220822
-
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
-
Astermark J, Morado M, Rocino A et al. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. Haemophilia 2006; 12: 363-71.
-
(2006)
Haemophilia
, vol.12
, pp. 363-371
-
-
Astermark, J.1
Morado, M.2
Rocino, A.3
-
3
-
-
34347360724
-
International workshop on immune tolerance induction: consensus recommendations
-
DiMichele DM, Hoots WK, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Haemophilia 2007; 13(Suppl 1): 1-22.
-
(2007)
Haemophilia
, vol.13
, pp. 1-22
-
-
DiMichele, D.M.1
Hoots, W.K.2
Pipe, S.W.3
Rivard, G.E.4
Santagostino, E.5
-
4
-
-
34447287337
-
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response
-
Gringeri A, Musso R, Mazzucconi MG et al. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Haemophilia 2007; 13: 373-9.
-
(2007)
Haemophilia
, vol.13
, pp. 373-379
-
-
Gringeri, A.1
Musso, R.2
Mazzucconi, M.G.3
-
5
-
-
84856866914
-
The principal results of the International Immune Tolerance Study: a randomized dose comparison
-
Hay CR, DiMichele DM. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 2012; 119: 1335-44.
-
(2012)
Blood
, vol.119
, pp. 1335-1344
-
-
Hay, C.R.1
DiMichele, D.M.2
-
6
-
-
84890858676
-
Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate
-
Oldenburg J, Jimenez-Yuste V, Peiro-Jordan R, Aledort LM, Santagostino E. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate. Haemophilia 2014; 20: 83-91.
-
(2014)
Haemophilia
, vol.20
, pp. 83-91
-
-
Oldenburg, J.1
Jimenez-Yuste, V.2
Peiro-Jordan, R.3
Aledort, L.M.4
Santagostino, E.5
-
7
-
-
84925954257
-
Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product
-
Rangarajan S, Jimenez-Yuste V, Santagostino E. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product. Haemophilia 2014; 20: e414-17.
-
(2014)
Haemophilia
, vol.20
, pp. e414-e417
-
-
Rangarajan, S.1
Jimenez-Yuste, V.2
Santagostino, E.3
-
8
-
-
80055106986
-
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
-
Kurth M, Puetz J, Kouides P et al. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience. J Thromb Haemost 2011; 9: 2229-34.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 2229-2234
-
-
Kurth, M.1
Puetz, J.2
Kouides, P.3
-
9
-
-
70449591451
-
Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate
-
Diez JM, Caballero S, Belda FJ, Otegui M, Gajardo R, Jorquera JI. Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate/Fanhdi, a human factor VIII/VWF complex concentrate. Haemophilia 2009; 15: 1249-57.
-
(2009)
Haemophilia
, vol.15
, pp. 1249-1257
-
-
Diez, J.M.1
Caballero, S.2
Belda, F.J.3
Otegui, M.4
Gajardo, R.5
Jorquera, J.I.6
-
10
-
-
44649136183
-
The role of VWF for the success of immune tolerance induction
-
Kreuz W. The role of VWF for the success of immune tolerance induction. Thromb Res 2008; 122(Suppl 2): S7-12.
-
(2008)
Thromb Res
, vol.122
, pp. S7-12
-
-
Kreuz, W.1
|